Medicine and Dentistry
Cystic Fibrosis
100%
Asthma
65%
Forced Expiratory Volume
39%
Wheeze
34%
Disease
24%
Childbirth
21%
Antibiotics
20%
Patient with Cystic Fibrosis
19%
Cohort Effect
18%
Symptom
17%
Lung Function
17%
Pediatrics
16%
Respiratory Disease
14%
Pseudomonas aeruginosa
13%
Toddlers
13%
Antibiotic Therapy
13%
Forced Vital Capacity
12%
Spirometry
11%
Lower Respiratory Tract
11%
Adolescent
11%
Obstructive Sleep Apnea
9%
Silo-Filler's Disease
9%
Coughing
9%
Cohort Analysis
8%
Preschooler
8%
Randomized Clinical Trial
8%
Placebo
7%
Sputum
7%
Patient Registry
7%
Atopy
7%
Chronic Obstructive Pulmonary Disease
7%
Physical Disease by Body Function
6%
Infancy
6%
Polysomnography
6%
Body Mass Index
5%
Odds Ratio
5%
Functional Residual Capacity
5%
Maximal Expiratory Flow
5%
Breathing
5%
Lung Development
5%
Observational Study
5%
Clinician
5%
Nitric Oxide
5%
Pseudomonas
5%
Growth, Development and Aging
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
74%
Asthma
66%
Wheezing
24%
Disease
17%
Antibiotics
12%
Symptom
12%
Placebo
11%
Epidemiology
11%
Antibiotic Agent
10%
Salbutamol
10%
Dornase Alfa
9%
Respiratory Tract Disease
8%
Randomized Clinical Trial
8%
Observational Study
8%
Respiratory Tract
7%
Physical Disease by Body Function
7%
Coughing
7%
Mild Persistent Asthma
6%
Omalizumab
6%
Chronic Obstructive Lung Disease
6%
Sleep Disordered Breathing
6%
Lung Disease
5%
Immunoglobulin E
5%
Keyphrases
Cystic Fibrosis
44%
Forced Expiratory Volume in 1 Second (FEV1)
31%
Asthma
20%
Lung Function
20%
Pulmonary Exacerbation
13%
Tucson
11%
Wheezing
10%
Inhaled Corticosteroids
8%
Dornase Alfa
7%
Decline in Lung Function
7%
Decline Rate
7%
Lower Respiratory Tract Infection
6%
Epidemiologic Studies
6%
Preschool children
6%
Theophylline
6%
Fluticasone Propionate
5%
Asthma Control
5%
Antibiotic Treatment
5%
Early childhood
5%
Risk Factors
5%
Intravenous Antibiotics
5%
